Hellmann Worldwide Logistics Pharmaceutical Import Profile — New Zealand (DGFT 2022–2026)

Name: Hellmann Worldwide Logistics Pharmaceutical Import Records from India — 3 Products, $3.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Hellmann Worldwide Logistics — Pharmaceutical Importer Profile (2026) | 3 Products, $3.7M Trade | TransData Nexus

Hellmann Worldwide Logistics

Pharmaceutical Importer · New Zealand · Analgesics & Antipyretics Focus · $3.7M Total Trade · DGFT Verified

Hellmann Worldwide Logistics is a pharmaceutical importer based in New Zealand with a total trade value of $3.7M across 3 products in 3 therapeutic categories. Based on 266 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Hellmann Worldwide Logistics sources from 3 verified Indian suppliers, with Cipla Limited accounting for 97.1% of imports.

Hellmann Worldwide Logistics — Import Portfolio & Supplier Network

Hellmann Worldwide Logistics import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Hellmann Worldwide Logistics?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$8.2M	1,316	97.1%
Milan Laboratories (india) Private Limited	$204.8K	7	2.4%
Medopharm Wellness Private Limited	$42.9K

What Formulations Does Hellmann Worldwide Logistics Import?

Formulation	Value	Ships
Ethics paracetamol 120 MG /5 ML oral	$726.0K	21
Ethics aspirin enteric coated 100 MG TAB	$505.5K	18
Ethics hydrocortisone cream 1%	$429.9K	38
Ethics ibuprofen oral suspension (100 MG/5ML) (ibuprofen oral suspension 100MG/5ML)	$397.1K	21
Ethics ibuprofen oral suspension (100 MG/5ML) (ibuprofen oral suspension 100MG/5ML) 1 x 200 ML	$270.5K	11
Ethics paracetamol 120 MG 5 ML oral suspension paracetamol 120 MG 5 ML oral	$250.9K	8
Ethics ibuprofen oral suspension 100 MG	$202.4K	12
Clomazol 2% vaginal cream ( with 3	$186.2K	9
Ethics ibuprofen oral suspension (100 MG	$182.9K	8
Ethics paracetamol 120MG/5ML oral suspension (paracetamol 120MG/5ML oral suspension)	$165.8K	10
Ethics hydrocortisone cream 1% (hydrocortisone cream 1% ) (1x30 GM)	$143.5K	13
Ethics aspirin enteric coated 100MG	$140.7K	6
Clomazol antifungal cream 1%	$138.9K	19
Ethics paracetamol 250MG/5ML children 6-12 years oral suspension (acetaminophen oral suspension USP 250	$138.7K	3
Ethics escitalopram 10 MG tablets	$135.7K	4

Hellmann Worldwide Logistics imports 429 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Aspirin	Analgesics & Antipyretics	$1.9M	122	5.0%	4
2	Salicylic	Combination Drugs	$1.2M	89	7.1%	3
3	Hydrocortisone	Corticosteroids	$618.4K	55	0.9%	12

Hellmann Worldwide Logistics imports 3 pharmaceutical products across 3 categories into New Zealand totaling $3.7M.

Hellmann Worldwide Logistics — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Hellmann Worldwide Logistics is a privately held global logistics provider headquartered in Osnabrück, Germany. Established in 1871, the company has expanded its operations to over 160 countries, offering a comprehensive range of services including air and ocean freight, road and rail transportation, contract logistics, and supply chain management.

In New Zealand, Hellmann Worldwide Logistics specializes in delivering on-time, temperature-sensitive international supply chain solutions to organizations within the agricultural, horticultural, seafood, and healthcare industries. Their services encompass warehousing, distribution, and logistics management, aiming to be an extension of their customers' businesses to ensure mutual longevity and success.

2Distribution Network

Hellmann Worldwide Logistics operates multiple facilities across New Zealand, including offices in Auckland, Lower Hutt, and Wellington. (cbaff.org.nz) Their logistics capabilities are designed to handle temperature-sensitive shipments, ensuring compliance with industry standards for the pharmaceutical sector. The company's geographic coverage extends throughout New Zealand, providing comprehensive supply chain solutions to meet the diverse needs of their clientele.

3Industry Role

In New Zealand's pharmaceutical supply chain, Hellmann Worldwide Logistics functions primarily as a logistics intermediary. While they are not directly involved in the wholesale distribution or parallel importation of pharmaceutical products, their role is crucial in ensuring the efficient and compliant transportation and storage of pharmaceutical goods. Their expertise in handling temperature-sensitive shipments aligns with the stringent requirements of the pharmaceutical industry.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Hellmann Worldwide Logistics

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Hellmann Worldwide Logistics' sourcing from India reveals a high concentration, with a total import value of $3.7 million USD across 266 shipments, primarily consisting of three products: Aspirin ($1.9 million, 5.0% share), Salicylic ($1.2 million, 7.1% share), and Hydrocortisone ($618,000, 0.9% share). This concentration indicates a strategic choice to source specific pharmaceutical formulations from India, leveraging the country's manufacturing capabilities and cost advantages. The stability of this relationship is suggested by the consistent number of shipments over the period, reflecting a reliable supply chain partnership.

2Supply Chain Resilience

The resilience of Hellmann Worldwide Logistics' Indian supply chain is supported by a diversified portfolio of 429 unique pharmaceutical formulations. This diversity mitigates risks associated with dependency on a limited number of products. However, the heavy reliance on a single supplier, CIPLA LIMITED, which accounts for 97.1% of the shipments, poses potential risks. To enhance supply chain resilience, it would be prudent for Hellmann to consider engaging additional suppliers and diversifying their sourcing strategies.

3Strategic Implications

Importing Pharmaceuticals into New Zealand — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for New Zealand

1Regulatory Authority & Framework

In New Zealand, the regulation of pharmaceutical imports is overseen by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. Medsafe administers the Medicines Act 1981 and associated regulations, ensuring that medicines imported into New Zealand meet safety, quality, and efficacy standards. The importation of controlled drugs is subject to additional regulations under the Misuse of Drugs Act 1975. (medsafe.govt.nz)

2Import Licensing & GMP

Importers of pharmaceutical products into New Zealand must comply with the Medicines Regulations 1984, which stipulate that all medicines must be securely packed to withstand transport and protect contents from damage. (legislation.govt.nz) Additionally, Good Manufacturing Practice (GMP) certification is required for pharmaceutical products. Medsafe recognizes GMP certificates from the European Union, World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), ensuring that imported medicines are manufactured to internationally recognized standards. (medsafe.govt.nz)

3Quality & Labeling

Hellmann Worldwide Logistics — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Hellmann Worldwide Logistics' focus on importing analgesics, combination drugs, and corticosteroids aligns with market demand in New Zealand for these therapeutic areas. Analgesics and antipyretics are essential for pain and fever management, combination drugs offer convenience and improved patient adherence, and corticosteroids are critical for treating inflammatory conditions. This strategic product selection positions Hellmann to meet the therapeutic needs of the New Zealand population effectively.

2Sourcing Profile

Hellmann Worldwide Logistics' sourcing strategy emphasizes generic pharmaceutical formulations, primarily from India, leveraging cost advantages and the country's manufacturing capabilities. This approach allows them to offer a diverse range of products while maintaining competitive pricing. India's compliance with international GMP standards further supports the quality and reliability of the sourced products.

3Market Positioning

Based on their product mix, Hellmann Worldwide Logistics serves the wholesale distribution segment of the New Zealand pharmaceutical market. By importing a range of pharmaceutical products, they supply these to various stakeholders, including retail pharmacies, hospitals, and healthcare providers, ensuring a steady and reliable supply of essential medicines.

Seller's Guide — How to Become a Supplier to Hellmann Worldwide Logistics

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Hellmann Worldwide Logistics by offering complementary products not currently in their portfolio or by enhancing the quality and reliability of existing offerings. Diversifying the supplier base can strengthen Hellmann's competitive position and resilience in the New Zealand market.

2Requirements & Qualifications

Indian exporters seeking to supply Hellmann Worldwide Logistics and the New Zealand market must ensure that their products comply with New Zealand's regulatory requirements, including obtaining GMP certification recognized by Medsafe. Additionally, products must meet labeling standards, including English language requirements and necessary information such as dosage instructions and storage conditions. Engaging with Medsafe and staying informed about regulatory updates is essential for successful market entry.

3How to Approach

Indian exporters should initiate contact with Hellmann Worldwide Logistics by presenting their product portfolio, emphasizing compliance with New Zealand's regulatory standards, and demonstrating the quality and reliability of their products. Participating in relevant tenders and industry events can enhance visibility and facilitate partnerships. Understanding the regulatory filing process and timelines for product registration with Medsafe is crucial to ensure timely market entry.

Frequently Asked Questions — Hellmann Worldwide Logistics

What products does Hellmann Worldwide Logistics import from India?

Hellmann Worldwide Logistics imports 3 pharmaceutical products across 3 categories. Top imports: Aspirin ($1.9M), Salicylic ($1.2M), Hydrocortisone ($618.4K).

Who supplies pharmaceuticals to Hellmann Worldwide Logistics from India?

Hellmann Worldwide Logistics sources from 3 verified Indian suppliers. The primary supplier is Cipla Limited (97.1% of imports, $8.2M).

What is Hellmann Worldwide Logistics's total pharmaceutical import value?

Hellmann Worldwide Logistics's total pharmaceutical import value from India is $3.7M, based on 266 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Hellmann Worldwide Logistics focus on?

Hellmann Worldwide Logistics imports across 3 categories. The largest: Analgesics & Antipyretics (51.1%), Combination Drugs (32.2%), Corticosteroids (16.7%).

Get Full Hellmann Worldwide Logistics Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.